Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atara Biotherapeutics, Inc. - Common Stock (NQ: ATRA )

6.970 +0.110 (+1.60%)
Streaming Delayed Price Updated: 9:30 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atara Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Atara Biotherapeutics Announces $15 Million Registered Direct Offering
From Atara Biotherapeutics, Inc.
Via Business Wire
Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
From Atara Biotherapeutics, Inc.
Via Business Wire
Atara Biotherapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Atara Biotherapeutics, Inc.
Via Business Wire
Where Atara Biotherapeutics Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. 
Via Benzinga
Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of Rocket Lab USA, Inc. (NASDAQ: RKLB) shares rose sharply in pre-market trading after the company announced a new $515 million contract with a U.S. government customer. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories
From Atara Biotherapeutics, Inc.
Via Business Wire
Atara Biotherapeutics Presents Positive Preclinical Data on ATA3431, A Next-Generation Allogeneic CD20/CD19-Targeted CAR, at the 65th ASH Annual Meeting
From Atara Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Atara Biotherapeutics, Inc.
Via Business Wire
Atara Biotherapeutics To Present Positive New Tab-cel® Clinical Data During Oral Session at ESMO Immuno-Oncology Annual Congress 2023
From Atara Biotherapeutics, Inc.
Via Business Wire
Atara Biotherapeutics to Participate at the 6th Annual Evercore ISI HealthCONx Conference
From Atara Biotherapeutics, Inc.
Via Business Wire
Atara Biotherapeutics To Participate at the Stifel Healthcare Conference
From Atara Biotherapeutics, Inc.
Via Business Wire
Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53.... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
US Stocks Mostly Flat; Jobless Claims Decline In Latest Week
U.S. stocks traded mostly flat this morning, following the release of jobless claims data. Following the market opening Thursday, the Dow traded down 0.02% to 34,105.13 while the NASDAQ rose 0.01% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why AppLovin Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares surged 111.9% to $0.4810 in pre-market trading after reporting first-quarter results. 
Via Benzinga
Astra Space (ASTR) Stock Spikes 82% on Take-Private Proposal
Astra Space stock is taking off on Thursday as investors react to a take-private offer for ASTR shares from the company's founders. 
Via InvestorPlace
Why Is Assertio (ASRT) Stock Down 39% Today?
Assertio stock is dropping on Thursday as investors in ASRT react to the company's poor earnings results for the third quarter of 2023. 
Via InvestorPlace
Why Is Atara Biotherapeutics (ATRA) Stock Down 50% Today?
Atara Biotherapeutics stock is falling on Thursday as investors in ATRA react to the company's latest Phase 2 clinical trial data. 
Via InvestorPlace
Why Atara Biotherapeutics Shares Are Plummeting Today
Atara Biotherapeutics, Inc. (NASDAQ: ATRA) shares are trading lower after the company said that primary analysis data from its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday morning! 
Via InvestorPlace
Atara Biotherapeutics Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis
From Atara Biotherapeutics, Inc.
Via Business Wire
Atara Biotherapeutics Announces Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories and Third Quarter 2023 Financial Results
From Atara Biotherapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.